Literature DB >> 9365499

Towards intelligent anticancer drug screening in the post-genome era?

P Workman1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9365499

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN： 0266-9536


× No keyword cloud information.
  4 in total

1.  Possible contribution of beta-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cells.

Authors:  Hossam M M Arafa
Journal:  Invest New Drugs       Date:  2009-05-05       Impact factor: 3.850

2.  Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent.

Authors:  H Seker; B Bertram; A Bürkle; B Kaina; J Pohl; H Koepsell; M Wiesser
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

3.  The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells.

Authors:  Reem T Attia; Mai F Tolba; Ruchit Trivedi; Mariane G Tadros; Hossam M M Arafa; Ashraf B Abdel-Naim
Journal:  PeerJ       Date:  2016-06-29       Impact factor: 2.984

4.  Chemical genetic screening of KRAS-based synthetic lethal inhibitors for pancreatic cancer.

Authors:  Zhenyu Ji; Fang C Mei; Pedro L Lory; Scott R Gilbertson; Yijun Chen; Xiaodong Cheng
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.